Skip to main content
Clinical Trials/NCT02553720
NCT02553720
Completed
Not Applicable

Aquatic Therapy to Lower Adverse and Negative Effects of Venous Thrombosis and InSufficiency

Arizona Cardiovascular Consultants1 site in 1 country181 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Venous Hypertension Due to Deep Vein Thrombosis
Sponsor
Arizona Cardiovascular Consultants
Enrollment
181
Locations
1
Primary Endpoint
4 point drop in modified VCSS
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to test whether addition of aquatic exercise to conventional treatment helps reduce the adverse outcomes of chronic venous insufficiency including CVI resulting from venous thrombosis.

Detailed Description

Post-thrombotic syndrome (PTS) develops in approximately 25-60% of patients with acute lower extremity deep venous thrombosis (DVT) depending on severity, chronicity, anatomic level of involvement and efficacy of anticoagulation.The frequency increases with occlusive iliac venous thrombosis. PTS results in significant morbidity and a staggering toll on health careresources . PTS is reduced by early percutaneous endovenous intervention and administration of new oral anticoagulants. There are conflicting results on the efficacy of exercise . In general, exercise has been useful in activation of the muscle pump and improvement of symptoms. There are no data about exercise in a swimming pool. Both walking in water or swimming reduce the effect of joint contact and therefore pain which is particularly useful in patients with arthritis or heavyweight. Furthermore with less effect of gravity, absorption of dependent edema would be faster. Dry skin becomes hydrated and the chlorine of water can exert antiseptic properties. There are no data on the role of aquatic activity in the reduction of measures of venous insufficiency.The purpose of this study is to assess whether encouragement of patients to perform aquatic activity in addition to baseline treatment would positively impact chronic venous insufficiency.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
January 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Arizona Cardiovascular Consultants
Responsible Party
Principal Investigator
Principal Investigator

Mohsen Sharifi MD

principal investigator

Arizona Cardiovascular Consultants

Eligibility Criteria

Inclusion Criteria

  • age\>18 years; a Villalta score of ˃5 or a modified Venous Clinical Severity Score (VCSS) of ˃5 plus ongoing symptoms of ˃3 months despite receiving conservative management (minimum of 2 of the following: compression stockings, leg elevation, physical activity on land and use of non-steroidal anti-inflammatory drugs where appropriate, for the preceding 3 months).
  • Exclusion criteria consisted of unwillingness or inability to use or no access to a swimming pool; open ulceration; planned intervention for arterial or superficial venous reflux, deep venous thrombosis (DVT), venous stenosis, pelvic congestion syndrome, within the first 3 months of enrolment; or using a swimming pool on a regular basis.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

4 point drop in modified VCSS

Time Frame: 3 months and 2 years

Modified VCSS score at baseline, 3 m and 2 years.

Secondary Outcomes

  • Viallta Score(3 months and 2 years)
  • Thigh and leg circumference(3 months and 2 years)
  • Mortality(2 years)
  • VEINES QOL/Sym(3months and 2 years)
  • Recurrent venous thromboembolic disease(3 months and 2 years)
  • SF 36 questionnaire-PHC(3 months and 2 years)
  • "Subjective Index" alteration(3 months and 2 years)
  • Modified Venous Clinical Severity Score(3months and 2 years)

Study Sites (1)

Loading locations...

Similar Trials